Ivonne Solis-Trapala's Outputs (3)

Talking About Risk in the Context of GEnomic Tests (TARGET): Development and evaluation of an educational program for clinicians (2019)
Journal Article
Fallowfield, L., Solis-Trapala, I., Starkings, R., Catt, S., May, S., & Jenkins, V. (2019). Talking About Risk in the Context of GEnomic Tests (TARGET): Development and evaluation of an educational program for clinicians. Breast Cancer Research and Treatment, 177, 641-649. https://doi.org/10.1007/s10549-019-05316-7

Purpose: Gene expression profiling (GEP) test scores calculate risks of recurrence and likely benefit of adjuvant chemotherapy in ER positive, HER2 negative, early stage breast cancer. As health literacy and numeracy skills in the general population... Read More about Talking About Risk in the Context of GEnomic Tests (TARGET): Development and evaluation of an educational program for clinicians.

multinbmod-package: Regression analysis of overdispersed correlated count data (2019)
Digital Artefact
Solis-Trapala, I. (2019). multinbmod-package: Regression analysis of overdispersed correlated count data. [Code]

Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death (2019)
Journal Article
Lambie, M., Teece, L., Johnson, D. W., Petrie, M., Mactier, R., Solis-Trapala, I., …Davies, S. J. (2019). Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death. Nephrology Dialysis Transplantation, 1585-1591. https://doi.org/10.1093/ndt/gfz034

Background
Risk of Encapsulating Peritoneal Sclerosis (EPS) is strongly associated with the duration of peritoneal dialysis (PD), such that patients who have been on PD for some time may consider elective transfer to haemodialysis to mitigate risk o... Read More about Estimating risk of encapsulating peritoneal sclerosis accounting for the competing risk of death.